932384-67-3

Basic information

• Product Name: (2-formyl-4-methyl-phenyl)-carbamic acid tert-butyl ester
• Synonyms: (2-formyl-4-methyl-phenyl)-carbamic acid tert-butyl ester
• CAS NO: 932384-67-3
• Molecular Weight: 235.283
• Mol File: 932384-67-3.mol

Chemical Properties

• CAS DataBase Reference: (2-formyl-4-methyl-phenyl)-carbamic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (2-formyl-4-methyl-phenyl)-carbamic acid tert-butyl ester(932384-67-3)
• EPA Substance Registry System: (2-formyl-4-methyl-phenyl)-carbamic acid tert-butyl ester(932384-67-3)

Safety Data

• Hazardous Substances Data: 932384-67-3(Hazardous Substances Data)

Upstream product

• 932384-66-2 (2-Hydroxymethyl-4-methyl-phenyl)-carbamic acid tert-butyl ester 
• 34897-84-2 2-amino-5-methylbenzyl alcohol 
• 2941-78-8 2-Amino-5-methylbenzoic acid 

Downstream Products

• 932384-69-5 [2-(1-hydroxy-2-methyl-propyl)-4-methyl-phenyl]-carbamic acid tert-butyl ester 

Relevant articles and documents

Pd-Catalyzed Three-Component Domino Reaction of Vinyl Benzoxazinanones for Regioselective and Stereoselective Synthesis of Allylic Sulfone-Containing Amino Acid Derivatives

A Pd-catalyzed, highly regioselective and stereoselective three-component domino allylic substitution/N-H carbene insertion reaction under mild conditions is described. This reaction demonstrates a wide substrate scope and satisfactory functional group tolerance, providing a broad range of allylic sulfone-containing amino acid derivatives. Moreover, DBU mediates highly diastereoselective cross-dehydrogenative coupling annulation of allylic sulfones without using peroxides or any metal oxidants. This developed protocol affords 7-membered ring heterocyclic compounds incorporating both sulfone-containing amino acid esters and one quaternary carbon center. Mechanistic studies indicate that an unusual umpolung of glycine occurred in this annulation.

Heterocyclic amide derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes

The present invention relates to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating RXR mediated disorders. More particularly, the compounds of the present invention are RXR agonists useful for treating RXR mediated disorders.